JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263333

Human RPS27L knockout HeLa cell lysate

Be the first to review this product! 리뷰 제출

|

(0 출판물)

RPS27L KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 5 bp deletion in exon2 and 7 bp deletion in exon2.
2 이미지
Sanger Sequencing - Human RPS27L knockout HeLa cell lysate (AB263333)
  • Sanger seq

Unknown

Sanger Sequencing - Human RPS27L knockout HeLa cell lysate (AB263333)

Allele-1 : 7 bp deletion in exon2

Sanger Sequencing - Human RPS27L knockout HeLa cell lysate (AB263333)
  • Sanger seq

Unknown

Sanger Sequencing - Human RPS27L knockout HeLa cell lysate (AB263333)

Allele-2 : 5 bp deletion in exon2

주요 정보

세포 유형

HeLa

Species or organism

Human

조직

Cervix

Knockout 검증

Sanger Sequencing

Mutation 정보

Knockout achieved by using CRISPR/Cas9, 5 bp deletion in exon2 and 7 bp deletion in exon2.

질병

Adenocarcinoma

제품 세부 정보

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

제품 구성

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263333-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human RPS27L knockout HeLa cell lysate", "number":"AB263333-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263333-CMP02", "productcode":"" } ] } } }

특성 및 보관 정보

유전자명
RPS27L
유전자 편집 종류
Knockout
유전자 편집 방식
CRISPR technology
Knockout 검증
Sanger Sequencing
배송 시 보관 조건
Ambient - Can Ship with Ice
적절한 단기 보관 조건
-20°C
적절한 장기 보관 조건
-20°C

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

RPS27L also known as Ribosomal Protein S27-like or Metallopanstimulin-1 (MPS-1) is a component of the ribosome with a molecular weight of approximately 9.5 kDa. It is expressed across various tissues particularly in liver and prostate. Mechanically RPS27L functions as part of the ribosomal machinery where it plays a role in the assembly and stability of ribosomal constituents necessary for protein synthesis.
Biological function summary

This protein contributes to the regulation of the cellular response to DNA damage and is involved in the control of cell cycle progression. It is part of the small subunit of the ribosome where it associates with other ribosomal proteins to form a functional ribosomal unit. Its activity emphasizes its importance in maintaining genomic stability and proper cellular functions.

Pathways

RPS27L plays a substantial role in the DNA damage response and the p53 signaling pathway. It interacts with the p53 protein an important tumor suppressor regulating p53 levels and activity following genotoxic stress. The interplay between RPS27L and p53 emphasizes its involvement in pathways that oversee damage repair mechanisms particularly by influencing p53-mediated transcriptional regulation and apoptosis.

RPS27L has notable associations with cancer and ribosomopathies. Aberrant function or expression of RPS27L can contribute to tumorigenesis often through its interplay with the p53 pathway. Additionally it connects with proteins such as MDM2 a critical regulator of p53 in the context of oncogenic disorders highlighting its potential as a therapeutic target in related malignancies.

품질 관리

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

제품 프로토콜

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com